Table 11 Relation between polidocanol injected and the US follow-up findings in both 2nd and 3rd sessions
Significance | P value | Complete occlusion (n 35) | Test value | P value | Significance | |
 Pol 2% (no. 6) | 5 | 1 | 10.9865 | .000918 | significant | |
 Pol 3% (no.42) | 8 | 34 | ||||
3rd visit US finding | Partial (n 3) | Complete occlusion (n, 10) | No recanalization (n, 35) | Test value | P value | Significance |
 Pol 2% (no. 6) | 2 | 3 | 1 | 1 | 0.000996 | Significant |
 Pol 3% (no. 42) | 1 | 7 | 34 | 34 | ||